Skip to main content
SpringerLink
Log in

In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Funke G, Bernard KA (2003) Coryneform gram-positive rods. In: Murray PM, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, Washington, DC, pp 472–501

    Google Scholar 

  2. Funke G, von Graevenitz A, Clarridge III JE, Bernard KA (1997) Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10:125–159

    PubMed  CAS  Google Scholar 

  3. Funke G, Alvarez N, Pascual C, Falsen E, Akervall E, Sabbe L, Schouls L, Weiss N, Collins MD (1997) Actinomyces europaeus sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol 47:687–692

    Article  PubMed  CAS  Google Scholar 

  4. Troxler R, Funke G, von Graevenitz A, Stock I (2001) Natural antibiotic susceptibility of recently established coryneform bacteria. Eur J Clin Microbiol Infect Dis 20:315–323

    Article  PubMed  CAS  Google Scholar 

  5. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing. 15th informational supplement. M100-S15. CLSI Publications, Wayne, PA

    Google Scholar 

  6. Steele Moore L, Schneider B, Holloway WJ (1997) Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes. J Antimicrob Chemother 39 (Suppl A):67–68

    Article  Google Scholar 

  7. Schülin T, Wennersten CB, Moellering RC, Eliopoulos GM (1997) In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria. Antimicrob Agents Chemother 41:1196–1202

    PubMed  Google Scholar 

  8. Soriano F, Fernández-Roblas R, Calvo R, García-Calvo G (1998) In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob Agents Chemother 42:1028–1033

    PubMed  CAS  Google Scholar 

  9. Jones RN, Biedenbach DJ, Anderegg TR (2002) In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species. Diagn Microbiol Infect Dis 42:119–122

    Article  PubMed  CAS  Google Scholar 

  10. Sánchez Hernández J, Mora Peris B, Yagüe Guirao G, Gutiérrez Zufiaurre N, Muñoz Bellido JL, Segovia Hernández M, García Rodgríguez JA (2003) In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. Int J Antimicrob Agents 22:492–496

    Article  PubMed  CAS  Google Scholar 

  11. Goldstein EJC, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT (2003) In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob Agents Chemother 47:337–341

    Article  PubMed  CAS  Google Scholar 

  12. Goldstein EJC, Citron DM, Merriam CV, Warren Y, Tyrrell K, Fernandez HT (2003) In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria. Antimicrob Agents Chemother 47:1968–1971

    Article  PubMed  CAS  Google Scholar 

  13. Wookey A, Turner PJ, Greenhalgh JM, Eastwood M, Clarke J, Sefton C (2004) AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro. Clin Microbiol Infect 10:247–254

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Microbiology and Hygiene, Gärtner and Colleagues Laboratories, Elisabethenstrasse 11, 88212, Ravensburg, Germany

    G. Funke

  2. Pfizer AG Suisse, 8052, Zürich, Switzerland

    R. Troxler

Authors
  1. G. Funke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Troxler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Funke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Funke, G., Troxler, R. In vitro activity of quinupristin and dalfopristin in combination and alone against coryneform bacteria. Eur J Clin Microbiol Infect Dis 24, 769–771 (2005). https://doi.org/10.1007/s10096-005-0036-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-005-0036-4

Keywords

Search

Navigation